Showing results (691-700 of 747) with videos related to

Sort By:
Pageof 75
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2014
Immune cell subset counts associated with graft-versus-host diseasePeter J Podgorny, Yiping Liu, Poonam Dharmani-Khan, et al.
Clinical Pharmacology and Therapeutics|February 24, 2022
PharmVar GeneFocus: CYP3A5Cristina Rodriguez-Antona, Jessica L Savieo, Volker M Lauschke, et al.
Pacing and Clinical Electrophysiology : PACE|May 9, 2001
Central clinical research issues in electrophysiology: report of the NASPE CommitteeM J Domanski, D P Zipes, D G Benditt, et al.
Clinical Pharmacology and Therapeutics|July 1, 2020
PharmVar GeneFocus: CYP2C19Mariana R Botton, Michelle Whirl-Carrillo, Andria L Del Tredici, et al.
European Journal of Human Genetics : EJHG|March 2, 2021
Novel variants in TUBA1A cause congenital fibrosis of the extraocular muscles with or without malformations of cortical brain developmentJulie A Jurgens, Brenda J Barry, Gabrielle Lemire, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2015
Low Counts of B Cells, Natural Killer Cells, Monocytes, Dendritic Cells, Basophils, and Eosinophils are Associated with Postengraftment Infections after Allogeneic Hematopoietic Cell TransplantationPeter J Podgorny, Laura M Pratt, Yiping Liu, et al.
Journal of Personalized Medicine|June 2, 2021
Multi-Institutional Implementation of Clinical Decision Support for APOL1, NAT2, and YEATS4 Genotyping in Antihypertensive ManagementThomas M Schneider, Michael T Eadon, Rhonda M Cooper-DeHoff, et al.
The Journal of Molecular Diagnostics : JMD|February 8, 2022
CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative ProjectAndrea Gaedigk, Erin C Boone, Steven E Scherer, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangementL M Pratt, R P Beckett, C L Bellamy, et al.
Pageof 75